ClinicalTrials.govpublic full text
Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT
leukemia, lymphocytic, acute, inotuzumab ozogamicin, donor lymphocyte infusion, relapsed b cell acute lymphoblastic leukemia, allogeneic hematopoietic stem cell transplantation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897005
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.